SCHEMBL30467786

SCHEMBL30467786

Cc1nnc(N)c2ccc(-c3ccc4c(c3)B(O)OC(C)C4)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24252345 1.00
SCHEMBL24252505 0.81 CA1 (0.49)
SCHEMBL24252647 0.80 CA12 (0.40)
SCHEMBL24252717 0.78
SCHEMBL30467674 0.77
Formic Acid SCHEMBL30451574 0.77 CA1 (0.47)
SCHEMBL30467769 0.77
Formic Acid SCHEMBL25266987 0.77 CA1 (0.47)
SCHEMBL24252288 0.77
Formic Acid SCHEMBL25212277 0.75 CA12 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185592-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF Annexon, Inc. (US) 2023-05-31 EP disclosed